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Abstract
Vagal neural crest-derived precursors of the enteric nervous system colonize the bowel by descending within the enteric mesenchyme.
Perpendicular secondary migration, toward the mucosa and into the pancreas, result, respectively, in the formation of submucosal and
pancreatic ganglia. We tested the hypothesis that netrins guide these secondary migrations. Studies using RT-PCR, in situ hybridization, and
immunocytochemistry indicated that netrins (netrins-1 and -3 mice and netrin-2 in chicks) and netrin receptors [deleted in colorectal cancer
(DCC), neogenin, and the adenosine A2b receptor] are expressed by the fetal mucosal epithelium and pancreas. Crest-derived cells
expressed DCC, which was developmentally regulated. Crest-derived cells migrated out of explants of gut toward cocultured cells
expressing netrin-1 or toward cocultured explants of pancreas. Crest-derived cells also migrated inwardly toward the mucosa of cultured
rings of bowel. These migrations were specifically blocked by antibodies to DCC and by inhibition of protein kinase A, which interferes
with DCC signaling. Submucosal and pancreatic ganglia were absent at E12.5, E15, and P0 in transgenic mice lacking DCC. Netrins also
promoted the survival/development of enteric crest-derived cells. The formation of submucosal and pancreatic ganglia thus involves the
attraction of DCC-expressing crest-derived cells by netrins.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
The enteric nervous system (ENS) is unique in its ability
to function independently of CNS control and in its resem-
blance to the CNS (Furness, 2000; Gershon, 1995, 1998,
1999; Gershon et al., 1994). The ENS is derived from
precursors that migrate to the gut from the neural crest (Le
Douarin and Teillet, 1973, 1974; Yntema and Hammond,
1954, 1955). Vagal crest-derived precursors migrate proxi-
modistally through the outer mesenchyme of the presump-
tive small intestine (Burns and Le Douarin, 1998, 2001;
Coventry et al., 1994; Kapur et al., 1992; Natarajan et al.,
1999; Young et al., 1998). Most of these cells form myen-
teric ganglia; however, a subset migrates perpendicularly
toward the mucosa and forms the submucosal plexus (Ger-
shon et al., 1993; McKeown et al., 2001; Payette et al.,
1984), while another subset migrates in the opposite direc-
tion out of the gut to form pancreatic ganglia (Kirchgessner
et al., 1992). The guidance factors responsible for determin-
ing the routes of crest-derived cell migration in the bowel
have not previously been identified.
Netrins attract or repel sets of axons, usually to or from
the midline, but also elsewhere, in worms, flies, and verte-
brates (Culotti and Merz, 1998; Serafini et al., 1994; Wang
et al., 1999). Netrins are members of a family of laminin-
related proteins, which include the UNC-6 gene product of
nematodes, netrins-A and -B of Drosophila, netrins-1 and -2
of chicks, netrin-3 of mice, and the NTN2L gene product of
humans. The chemoattractant effects of netrins are mediated
by the deleted in colorectal cancer (DCC) family of plas-
malemmal receptors, which includes the UNC-40 protein of
nematodes, the Frazzled protein of Drosophila, and DCC
and neogenin in vertebrates. The adenosine A2b receptor
also binds netrins, and evidence for (Corset et al., 2000) and
against (Stein et al., 2001) the idea that it acts with DCC as
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a coreceptor has been reported. Netrins function, not only in
axonal guidance, but also in neuronal migration and sur-
vival in the ventricular zone of the brainstem (Llambi et al.,
2001), inferior olive (Bloch-Gallego et al., 1999), and pon-
tine nuclei (Serafini et al., 1996). Whether effects of netrins
are attractive or repulsive depends on coreceptors, such as
the UNC-5 gene product, with which DCC interacts (Barrett
and Guthrie, 2001; Hong et al., 1999), and the level of
cAMP within navigating growth cones (Hopker et al., 1999;
Ming et al., 1997).
Migrating crest-derived cells and the growth cones of
spinal axons respond to some of the same signals. Netrin-3,
moreover, has been found in the developing murine PNS
(Seaman and Cooper, 2001). We therefore tested the hy-
pothesis that netrins are expressed in the developing gut and
pancreas and function in the guidance of DCC-expressing
enteric crest-derived cells. Our observations suggest that the
netrin-dependent attraction of DCC-expressing crest-de-
rived cells plays a critical role in the formation of the
submucosal plexus of the bowel and ganglia in the pancreas.
Materials and methods
Animals
Fertile eggs from White Leghorn chickens (Gallus gal-
lus) and quails (Coturnix coturnix japonica) were obtained
from Truslow Farms (Chestertown, MD) and Karasoulas
Farms (Lake Elsinore, CA), respectively, and incubated at
37°C. CD-1 mice and timed pregnant rats were obtained
from Sprague-Dawley (Charles River, Waltham, MA) and
killed by exposure to CO2. This procedure has been ap-
proved by the Animal Care and Use Committee of Colum-
bia University. Rodent pregnancies were timed from the day
a vaginal plug was discovered, which was considered E0.
Fetuses from transgenic mice lacking DCC (Fazeli et al.,
1997) were from the laboratory of Dr. M. Tessier-Lavigne
(Department of Biological Sciences, Howard Hughes Med-
ical Institute, Stanford University).
Immunoselection
The monoclonal antibody, HNK-1, was either prepared
from the supernatants of cultured hybridoma cells (Ameri-
can Type Culture Collection, Manassas, VA) or purchased
from Biomeda (Foster City, CA). HNK-1 is a marker for
crest-derived cells in the chick (Tucker et al., 1984, 1988;
Vincent et al., 1983; Vincent and Thiery, 1984) and rat
(Erickson et al., 1989) gut. These antibodies were used to
isolate crest-derived and non-crest-derived cells from the
fetal gut by positive and negative immunoselection (Chala-
zonitis et al., 1997a; Pomeranz et al., 1993). Guts were
pooled from 15–20 chick embryos (E6), transferred to a
Ca2/Mg2-free solution (137 mM NaCl, 5.3 mM KCl, 1.1
mM Na2HPO4, 1.1 mM KH2PO4, 0.6 mM D-Glucose, pH
7.2–7.4), and minced. The minced tissue was incubated with
collagenase A (5 mg/ml; Roche Molecular Biochemicals,
Indianapolis, IN) at 37°C for 30 min, followed by trituration
and filtration to produce a suspension of single cells. The
resulting cell suspension was subsequently incubated for 60
min at 4°C with a 1:50 dilution of HNK-1 antibodies. The
incubation was terminated by a brief rinse with serum-free
medium. The rinsed cells were then exposed at 4°C for 15
min to goat anti-mouse secondary antibodies coupled to
magnetic microbeads (Miltenyi Biotec Inc., Auburn, CA).
The antibody-decorated cells were then passed through a
column in which they were selected with a magnetic field.
The crest-derived cells are retained on the column by the
magnetic field while the residual non-crest-derived cells
pass through. The crest-derived cells were finally released
from the magnetic field and washed out of the columns.
Tissue culture
Explants
Segments of preumbilical bowel distal to the gizzard
were removed from E5 chick or quail embryos and cut
transversely to obtain thin, but complete, rings of tissue. The
resulting enteric rings were plated on 12-mm coverslips
coated with NH4OH-polymerized rat tail collagen. Explants
of pancreas were prepared by cutting the dorsal pancreatic
bud away from the foregut, taking care not to include bowel.
When explants of gut and pancreas were to be cocultured,
the enteric explants were first incubated for 30 min at 37°C
with a marker, 5-chloromethylfluoroscein diacetate (Cell-
Tracker Green; 5 M in MEM; Molecular Probes, Eu-
gene, OR) to allow migrating crest-derived cells from the
bowel to be traced. The labeled rings of bowel were then
plated on 12-mm collagen coverslips, and the explants of
pancreas were plated next to them at a distance of 300–600
m. The individual explants and the explants of Cell-
Tracker-labeled gut  pancreas were cultured in an explant
medium containing 10% horse serum and 2% chick embry-
onic extract (CCE), in DMEM for 40 h.
Expression of netrin-1 in stably transfected cells
Control HEK293 cells (InVitrogen, Carlsbad, CA) and
HEK293 cells stably transfected with a construct encoding
netrin-1 tagged at the C terminus with a myc epitope (sup-
plied by Dr. M. Tessier-Lavigne) (Keino-Masu et al., 1996)
were plated on plastic in petri dishes and maintained in a
medium consisting of DMEM supplemented with 10% heat-
inactivated fetal bovine serum, 0.5% glutamine and pen/
strep, 200 g/ml Hygomycin B (Roche Molecular Bio-
chemicals), and 250 g/ml Geneticin (G418 sulfate; Gibco
BRL, Life Technologies). The transfected cells HEK293,
but not the HEK293 controls, could be immunostained with
antibodies to Myc (monoclonal 9E10; Santa Cruz), verify-
ing that the transfected cells expressed the netrin-1 con-
struct. Control and transfected HEK293 cells were har-
vested by rapid flushing and resuspended in DMEM
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containing 10% heat-inactivated fetal bovine serum. Drops
of the resuspended cells (20 l; 5,000,000 cells/ml) were
placed onto the lids of 35-mm culture dishes and inverted
over dishes that contained 2 ml DMEM. The resulting
hanging drops were incubated for 2 days at 37°C. Aggre-
gates of cells were then harvested with a 200-l pipette for
use in cocultures with explants of gut or dissociated enteric
cells. The harvested aggregates of netrin-1-secreting and
control 293-EBNA cells were finally embedded in rat-tail
collagen (Coulter et al., 1988) for coculture either with
explants of gut or with dissociated enteric cells. For cocul-
ture with explants of bowel, aggregates of 293-EBNA cells
were positioned 300–600 m from the gut and a micro-
drop of diluted rat tail collagen (5 l, diluted 1:10 in
MEM; Upstate Biotechnology, Lake Placid, NY) was
added to cover both. The explants and the 293-EBNA cells
were thus both embedded in a three-dimensional collagen
gel.
Culture of immunoselected cells from the embryonic chick
gut
Positively and negatively immunoselected cells were
separately plated (6.0 104 cells per well) on 12-mm round
glass coverslips coated with poly-D-lysine (20 g/ml;
Sigma) and rat-tail collagen. Cultures of mixed cells disso-
ciated from the embryonic bowel without prior immuno-
selection were also separately plated and treated similarly.
The crest-derived (positively selected) and non-crest-de-
rived (negatively selected) obtained by immunoselection
and the mixed cells were then maintained for 40 h in a
medium consisting of DMEM supplemented with 4.0%
horse serum. To assess the effects of netrin-1 on the cultures
of dissociated enteric cells, they were cocultured with col-
lagen-embedded 293-EBNA cells, which were or were not
(control) expressing netrin-1. The position of the 293-
EBNA cells was thus fixed, while the dissociated enteric
cells spread randomly over the dish. Alternatively, enteric
cells were cultured for 16 h in the same reduced-serum
medium; however, the medium was supplemented with pu-
rified netrin-1 (Serafini et al., 1994). Cultures were fixed for
analysis by immunocytochemistry to terminate the experi-
ments.
Immunocytochemistry and histochemistry
Freshly removed chick embryos, fetal mice, dissected
segments of bowel, or cultures were fixed for 3 h at room
temperature or overnight at 4°C in a solution containing 4%
formaldehyde (from paraformaldehyde) in 0.1 M sodium
phosphate buffer (pH 7.4). All preparations, except the
cultures (which were processed as whole mounts), were
rinsed with the same buffer, infiltrated with 30% sucrose,
and rinsed. They were then embedded in OCT medium
(Lipshaw), frozen in liquid N2, sectioned (at 10 m) with a
cryostat-microtome, and thaw-mounted on chromium alum-
gelatin-coated glass slides. Tissues were permeabilized and
blocked by incubation in PBS containing 0.4% Triton
X-100 and 4.0% horse serum. Primary antibodies (Table 1)
were applied overnight in a humidified chamber at 4°C.
Sites of antibody binding were detected by incubation for
2 h at room temperature with appropriate secondary anti-
bodies labeled with fluorescein isothiocyanate (FITC), cya-
nine-3 (Cy3), biotin, or alkaline phosphatase (Table 2).
Biotinylated secondary antibodies were detected by the
ABC method (Elite kit; Vector Laboratories, Burlingame,
CA). Peroxidase activity was visualized with H2O2 and 3,
3-diaminobenzidinesubstrate (DAB). Alkaline phosphatase
activity was demonstrated with nitroblue tetrazolium chlo-
ride (NBT) and 5-bromo-4-chloro-3-indolyl-phosphate
(BCIP) in a buffer containing 50 mM MgCl2, 1% Tween 20,
100 mM NaCl, and Tris–HCl at pH 9.5. For double labeling,
primary antibodies raised in different species were em-
ployed and the species-specific secondary antibodies were
coupled to contrasting fluorophores. To enhance the antige-
nicity of netrins in the chick gut, sections, mounted on
slides, were submerged in 0.01 M Na citrate (pH 6.0) and
Table 1
Primary antibodies utilized in the current study
Antigen Species Dilution Source
PGP9.5 (ubiquitin hydrolase) Rabbit 1:500 Biogenesis Ltd. Poole, United Kingdom
HNK-1 Mouse 1:1000 Biomeda Corp., Foster City, CA
QCPN Mouse 1:5 Monoclonal antibody developed by M. Bruce and Jean
Carlson was obtained from the Developmental Studies
Hybridoma Bank, University of Iowa, under NIH contract
HD-7-3263 (Liem, 1995)
Mouse glucagon Rabbit 1:200 Chemicon International, Temecula, CA
Chick pan-netrin Rabbit 1:100 Prepared in the laboratory of M. Tessier-Lavigne, University
of California, San Francisco, CA (Deiner et al., 1997)
Human DCC Mouse 1:100 Oncogene, Cambridge, MA (Deiner et al., 1997)
Mouse netrin-1 Goat 1:100 Santa Cruz Biotechnology, Santa Cruz, CA
Mouse DCC Goat 1:200 Santa Cruz Biotechnology, Santa Cruz, CA
Mouse A2b adenosine receptor Goat 1:200 Santa Cruz Biotechnology, Santa Cruz, CA
Digoxigenin Sheep 1:500 Roche Molecular Biochemicals, Indianapolis, IN
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boiled for 10 min prior to incubation with primary antibod-
ies (Deiner et al., 1997). Acetylcholinesterase (AChE) ac-
tivity was demonstrated histochemically as previously de-
scribed (Blaugrund et al., 1996; Karnovsky and Roots,
1964).
RNA isolation and RT-PCR
Total RNA was isolated from chick and mouse gut (RNA
STAT-60; Tel-Test Inc., Friendswood, TX), and DNA con-
tamination was removed with RNase-free DNase I (Pro-
mega, Madison, WI) for 30 min at 37°C. Then, 2 g of total
RNA was used to synthesize cDNA with random primers
and MuLV reverse transcriptase (GeneAmp RNA PCR kit;
Applied Biosystems, Foster City, CA) in 25 l of reaction
mixture at 42°C for 30 min. The PCR mixture (25 l)
consisted of 5 l cDNA, 3.75 pmol each of 3 and 5
primers, 0.25 mM dNTP, 2.5 l PCR buffer, and 1.0 U of
Taq polymerase. cDNA was amplified in a thermal cycler
(Inotech Biosystems, Lansing, MI) set with the following
parameters for all primer pairs: denaturation at 95°C (5 min
initial cycle, 1 min each subsequent cycle for 30 cycles),
annealing at a temperature noted below for 40 s, and exten-
sion at 60°C for 1.0 min each cycle for 30 cycles. The sense
and anti-sense primers, Mg2 concentrations, and annealing
temperatures used are listed in Table 3. The polymerase
chain reaction (PCR) was carried out by using the following
primers: chick netrin-1, chick netrin-2, mouse netrin-1,
mouse netrin-3, chick neogenin, mouse DCC, and  actin.
After the final PCR cycle, the reaction was extended for an
additional 10 min at 72°C, and the reaction products were
then cooled to room temperature. PCR products were re-
solved by electrophoresis through a 1% agarose gel and
visualized with ethidium bromide (0.3 g/ml). The PCR
products were sequenced to confirm their identity. To do so,
PCR products were subcloned into a pCR II cloning vector
by using a commercial kit (TA Cloning Kit; Invitrogen,
Carlsbad, CA). Plasmid DNA was isolated (Wizard Mini-
preps, Promega) and sequenced by dye termination (ABI
Automated Sequencer, Perkin Elmer) in the core facility of
Columbia University. The PCR products corresponding to
chick netrin-1 and chick netrin-2 were identified by diges-
tion at appropriate sites with the AvaII and PstI restriction
enzymes. The final cDNA sequences were compared with
those in the GenBank (Blast search at National Center for
Table 2
Secondary antibodies utilized in the current study
Antibody Coupled to Ig Dilution Visualized Source
Goat anti-mouse Cy3 IgG 1:1000 Fluorescence Jackson ImmunoResearch, West Grove, PA
Goat anti-rabbit Cy3 IgG 1:1000 Fluorescence Jackson ImmunoResearch, West Grove, PA
Goat anti-rabbit FITC IgG 1:400 Fluorescence Jackson ImmunoResearch, West Grove, PA
Goat anti-rabbit biotin IgG 1:200 ABC/DAB Vector Laboratories, Burlingame, CA
Donkey anti-rabbit Cy3 IgG 1:500 Fluorescence Jackson ImmunoResearch, West Grove, PA
Donkey anti-goat Cy3 IgG 1:1000 Fluorescence Jackson ImmunoResearch, West Grove, PA
Donkey anti-goat FITC IgG 1:400 Fluorescence Jackson ImmunoResearch, West Grove, PA
Rabbit anti-sheep biotin IgG 1:200 ABC/DAB Vector Laboratories, Burlingame, CA
Horse anti-mouse Alkaline phosphatase IgG 1:200 NBT/BCIP Vector Laboratories, Burlingame, CA
Table 3
PCR primers utilized in the current study
Proteins Antisense primer Sense primer (bp) Mg2/°C
Used with RT-PCR
-actin 5-GTGGGCCGCTCTAGGCACCAA-3 5-CTCTTTGATGTCACGCACACGATTTC-3 508 2 mM/60
Mouse netrin-1 5-TGACTGTAGGCACAACACGG-3 5-CTCCATGTTGAATCTGCAGC-3 153 2 mM/60
Mouse netrin-3 5-TGGCTGGTTGACTTACAGCG-3 5-ACAAGAGCGATGGTCCCTC-3 152 2 mM/58
Mouse DCC 5-CCAAGGTCGTCATGGAGATG-3 5-TGGGCACTTTCTAGTGTTGG-3 620 2.5 mM/60
Mouse neogenin 5-TACACTCCAGTGCCAGATCC-3 5-GCCGGGTACAAAAGACAGCA-3 856 2.5 mM/60
Chick netrin-1 5-CAAGGGGAAGCTGAAGATCA-3 5-TCTTCATGGGCTTCACCTTG-3 223 2.5 mM/60
Chick netrin-2 5-ATCAACCCGACCTCTCTTGT-3 5-TGCTGATCTGGATTTTGGGG-3 288 2.5 mM/60
Chick neogenin 5-TCTAGCACCAGCTACAACGG-3 5-GGATTTCCCCATTGCCAGAC-3 421 2.5 mM/60
Used with quantitative PCR
Mouse DCC 5-CCAACACTAGAAAGTGCCCA-3 5-AGTTGCTTCATTAGCCCTTC-3 556 2.5 mM/60
Chick netrin-1 5-AGGGAGAAGAAAGGGAAGTG-3 5-GGCAGAAGGTTTTGCTCAAG-3 412 2.5 mM/60
Chick neogenin 5-CCCAAGATGTTGTTGTGCGG-3 5-TCGGAACTTCAGGAACACGG-3 362 2.5 mM/60
Chick A2b 5-ACTTCCGCTACACCTTCCAC-3 5-TGAACTGCACTCAGTCTCCC-3 326 2.5 mM/60
Used to clone cDNA encoding DCC for in situ hybridization
Mouse DCC 5-GAAAGTGCCACCACTCGTTC-3 5-TGGGCACTTTCTAGTGTTGG-3 1351 3 mM/60
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Biotechnology Information, Bethesda, MD) to confirm their
identity.
Competitive PCR was used to compare quantitatively the
expression of netrin-1, DCC, neogenin, and the adenosine
A2b receptor at a variety of ages (Uberla et al., 1991).
Competitor DNA fragments for quantitative PCR were ob-
tained by using mouse-specific primers to amplify DNA
from chicks and chick-specific primers to amplify DNA
from mouse under low-stringency annealing conditions
(45°C; 30 cycles). These artificially created fragments
match the primer ends of the target DNA and thus can be
used to quantify the target DNA amplified by these primers.
The competitor DNA fragments differ in size from the
corresponding target DNA and are readily distinguished
from them by agarose gel electrophoresis. After electro-
phoresis, fragments of appropriate size were excised and
subcloned for sequencing as described above to verify that
the competitor DNA did not overlap with the PCR products
amplified from the targets. Differing amounts of competitor
DNA were added to each sample prior to their amplification
(Table 3). For quantitative analysis, the fluorescence of the
agarose gels was photographed, scanned, and digitized. The
optical density of the digitized images was analyzed by
using Kodak Digital Science 1D Image Analysis v.1.51
software (Eastman Kodak Company, Rochester, NY) with a
Macintosh computer.
In situ hybridization
A digoxigenin-labeled cRNA probe was prepared from
mouse brain cDNA encoding a segment (nucleotides 2601–
3952) of the sequence of DCC. The cloned plasmid DNA
was linearized with either NotI or BamHI, purified, and T7
and SP6 RNA polymerases were used to transcribe, respec-
tively, anti-sense and sense cRNA probes. Digoxigenin-
labeled cRNA probes for mouse netrin-1, chick netrin-2,
and rat DCC were prepared, respectively, from plasmids
pMNET-3 UTR, pCM25, and D-24 (supplied by M.
Tessier-Lavigne). The riboprobes were subjected to alkaline
hydrolysis before precipitation to reduce their sizes to200
bp in order to improve tissue penetration (Schaeren-Wiem-
ers and Gerfin-Moser, 1993). The riboprobes were quanti-
fied by dot blotting by using a commercially supplied pro-
tocol (DIG-RNA labeling kit; Roche Molecular
Biochemicals, Indianapolis, IN). In situ hybridization (Con-
lon and Rossant, 1992) was carried out by incubating sec-
tions with sense (control) or anti-sense probes (0.2–0.5
ng/l; in 100-l wells) in a moist chamber at 60°C for 16 h.
The hybridization buffer contained 50% formamide, 5
saline sodium citrate buffer (SSC; pH 4.5), 50 g/ml yeast
Fig. 1. mRNA encoding netrins can be found by RT-PCR in the developing
gut of chicks and mice. (A) Chick gut. mRNA encoding netrin-2 but not
netrin-1 is found. E, the age of development at which the gut was analyzed; fg,
foregut; hg, hindgut; wg, whole gut; br, brain (analyzed as a positive control).
(B) Chick pancreas. As in the bowel, mRNA encoding netrin-2 but not netrin-1
can be detected. (C) Mouse gut. E, ages of fetal mice; P, ages of postnatal
mice. (D) Chick gut. Competitive PCR. The expression of netrin-2 in the
developing bowel is developmentally regulated and peaks at E12.
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tRNA, 1% sodium dodecyl sulfate (SDS), and 50 g/ml
heparin. Following hybridization, preparations were washed
four times in 5 SSC (pH 4.5)/1% SDS/50% formamide at
60°C, and three times in 5 SSC (pH 4.5)/50% formamide
at 55°C. Bound digoxigenin was detected with antibodies
coupled to alkaline phosphatase (diluted 1:1500; Roche) or
HRP (ABC method, Elite kit; Vector Laboratories). Alka-
line phosphatase activity was demonstrated and visualized
Fig. 2. The cellular locations of netrin transcripts and immunoreactivity were analyzed in the developing gut and pancreas by in situ hybridization and
immunocytochemistry. (A) Chick proventriculus at E5. Antisense probe. Transcripts encoding netrin-2 are found in basal epithelial cells and in cells within
the outer gut mesenchyme in the region of developing myenteric ganglia. (B) Chick proventriculus at E5. Sense probe (control). No cells are labeled. (C,
D) Chick proventriculus (C) and gizzard (D) at E5. Antisense probe. At higher magnification, the labeled cells (arrows) of the outer gut mesenchyme are seen
to form aggregates and the epithelial labeling (D) to be sharply restricted to the basal cytoplasm. (E) Chick duodenum at E5. Antisense probe. Transcripts
encoding netrin-2 are found in developing myenteric ganglia and in the basal cytoplasm of epithelial cells. (F) Mouse spinal cord at E13 (examined as a
positive control). Antisense probe. Transcripts encoding netrin-1 are located in the floor plate (arrow). (G) Mouse duodenum at E13. Antisense probe.
Transcripts encoding netrin-1 are located in the outer gut mesenchyme (region of developing myenteric ganglia; arrows) and the mucosal epithelium. (H)
Mouse duodenum at E13. Sense probe (control). No cells are labeled. (I) Mouse pancreas at E13. Antisense probe. Transcripts encoding netrin-1 are located
in the basolateral cytoplasm of acinar cells (arrows). (J) Mouse pancreas at E13. Sense probe (control). No cells are labeled. (K) Chick small intestine at E7.
Netrin immunoreactivity is found in mucosal epithelial cells and diffusely in the outer gut mesenchyme (arrows). Immunoreactivity appears to be concentrated
in the region of the mucosal basement membrane (arrowhead). (L) Chick spinal cord at E7 (analyzed as a positive control). Immunoreactivity is confined
to the floor plate. (M) Chick gut and pancreas at E5. Netrin-immunoreactive cells are present in the dorsal pancreatic bud (arrows) and inset. (N) Chick small
intestine at E7 fixed after incubation for 4 hrs with brefeldin A. Netrin immunoreactivity (arrows) has accumulated in cells of the outer gut mesenchyme.
(O) Mouse spinal cord at E13 (analyzed as a positive control). Netrin immunoreactivity is located in the floor plate (arrow). (P) Mouse small intestine at E13.
Netrin immunoreactivity (arrows) is found in cells of the outer gut mesenchyme in the region where crest-derived cells are known to migrate and in the
mucosal epithelium. (Q) Mouse pancreas at E13. Netrin immunoreactivity is concentrated in the basolateral cytoplasm of acinar cells. (R) The same section
as in (Q) but the light is filtered to demonstrate the immunoreactivity of glucagon, a marker for developing islets of Langerhans. The immunoreactivities of
netrin (Q) and glucagon (R) do not coincide. Scale bars: (A–E) 50 m; (F–J) 100 m; (K) 25 m; (L) 50 m; (M, N) 25 m; (O–R) 50 m.
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with nitroblue tetrazolium chloride (NBT) and 5-bromo-4-
chloro-3-indolyl-phosphate (BCIP) (Roche) in a buffer con-
taining 100 mM NaCl, 50 mM MgCl2, 1% Tween 20, and
100 mM Tris–HCl at pH 9.5. The endogenous alkaline
phosphatase activity of the intestines was inhibited by in-
cubating tissues with 250 g/ml levamisole (Sigma).
Western blotting
The entire bowel from 15 chick embryos (E6) was ho-
mogenized in cold lysis buffer (Tris 0.02 M, Triton 0.1%,
EDTA 1 mM) containing a commercial cocktail of protease
inhibitors [diluted 1:10; a mixture of 4-(2-aminoethyl)ben-
zenesulfonyl fluoride, aprotinin, leupeptin, bestatin, and
pepstatin A; Sigma]. When Western blots were used to
analyze the effects of caspase and/or metalloprotease on
DCC, the caspase inhibitors VI (100 M) and III (25 M)
and metalloprotease inhibitor III (20 M) (all from Calbio-
chem, San Diego, CA) were also added to the protein
samples. The lysate was centrifuged at a low speed to
remove debris, and the protein content of the supernatant
was determined (Bio-Rad Laboratories, Richmond, CA).
The supernatant was then boiled for 5 min at 95°C in
Laemmli solution (Bio-Rad) containing 0.35 M dithiothre-
itol. An aliquot containing 20 g of protein was subjected to
SDS-PAGE (10% polyacrylamide). The separated proteins
were electrophoretically blotted onto a nitrocellulose sheet
for Western analysis. The blots were bleached for 5 min
with 6% H2O2 and blocked by incubation for 2 h in TBST
buffer (Tris 0.05 M, NaCl 0.15 M, Tween 0.05%) contain-
ing 5% fat-free milk. Immunoreactivity was identified with
appropriate secondary antibodies (Table 2) conjugated to
horseradish peroxidase (HRP; diluted 1:5000; Jackson
Labs, West Grove, PA). HRP activity was visualized with
4-chloro-1-naphthol (4-CN Kit; Bio-Rad).
Results
Netrins and their receptors are expressed in the
developing bowel and pancreas of chicks and mice
Transcripts encoding netrins are present in developing
gut and pancreas
Initial experiments employed RT-PCR to determine
whether transcripts encoding one or more netrins could be
detected in the developing bowel and pancreas of chicks
(E5-E19) and mice (E11-P14). The E11 chick brain was
studied as a positive control. Transcripts encoding netrin-2
were found in the chick gut at the earliest age examined, E5,
and continued to be present through E19 (Fig. 1A). Tran-
scripts encoding netrin-1 were not detected in the bowel but
were found in the E11 brain, suggesting that if netrin-1 is
expressed in the chick gut at all, its level of expression must
be extremely low. Competitive PCR revealed that netrin-2
expression in the chick bowel is developmentally regulated
(Fig. 1D). Expression was maximal as a function of age at
E12 and declined at E19 to20% maximal. As in the chick
gut, transcripts encoding netrin-1 were found at E7 and E13
in the chick pancreas (Fig. 1B), but those encoding netrin-1
were not detected at either age. Transcripts encoding two
netrins, netrin-1 and netrin-3, were detected in both the fetal
(E11–E15) and neonatal (P0–P14) murine bowel (Fig. 1C).
Sites of netrin expression in the enteric viscera of devel-
oping chicks (E5) and mice (E13) were located by in situ
hybridization. The floor plate of the developing murine
spinal cord (E13) was analyzed as a positive control. mRNA
encoding netrin-2 was found to be expressed in the mesen-
chyme of the outer bowel and in the basal regions of
epithelial cells in the chick preventriculus (Fig. 2A–C),
gizzard (Fig. 2D), and duodenum (Fig. 2E). No labeling was
observed when sections of chick gut were hybridized with a
sense riboprobe (Fig. 2B). mRNA encoding netrin-1 was
found in the floor plate of the murine spinal cord (Fig. 2F),
and its distribution in the fetal mouse intestine, in the outer
gut mesenchyme and epithelium, was similar to that in the
bowel of chicks (Fig. 2G and H). mRNA encoding netrin-1
was also found in the primordial mouse pancreas, where it
was prominent in the basal cytoplasm of acinar cells (Fig. 2I
and J). No labeling was observed when sections of mouse
gut or pancreas were hybridized with a sense riboprobe (Fig.
2H and J).
Netrin immunoreactivity is present in the developing gut
and pancreas
Netrin immunoreactivity was located in the chick gut,
pancreas, and spinal cord, which was processed as a positive
control. Netrin immunoreactivity was detected in the bowel
and pancreas at E5–E10 and in the spinal cord at E7. In the
gut, netrin immunoreactivity was found in a diffuse pattern
that outlined cells in the region of the presumptive circular
Fig. 3. DCC, neogenin, and the adenosine A2b receptor are expressed in the developing gut and pancreas of chicks and mice. (A) mRNAs encoding DCC
and neogenin can be detected in the developing mouse gut (E11–P14) by RT-PCR. (B) mRNA encoding neogenin can be detected in the developing chick
gut (E4–E19). fg, foregut; hg, hindgut; wg, whole gut; br, brain. (C) Immunoblots probed with antibodies to DCC in the absence (lane 1) or presence (lane
2) of inhibitors of caspases and metalloproteases. The protein band at 150 kDa (arrowhead), the expected size of the full-length DCC, is more intense when
protein was extracted in the presence of inhibitors of caspases and metalloproteases. (D) Expression of mRNA encoding DCC analyzed with competitive PCR
in the developing mouse gut. DCC expression is developmentally regulated. Note that the level of DCC expression in the postnatal gut is quite low relative
to that in the fetal bowel (maximal E13-E15). (E) Expression of mRNA encoding neogenin analyzed with competitive PCR in the developing chick gut.
Neogenin expression gradually declines as a function of age. (F) Expression of mRNA encoding the adenosine A2b receptor analyzed with competitive PCR
in the developing chick gut. Adenosine A2b receptor expression declines as a function of age. (G) Competitive PCR. mRNAs encoding neogenin and the
adenosine A2b receptor can be detected in the chick pancreas at E7.5 and E13.
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muscle and in the mucosal epithelium and its underlying
basement membrane (Fig. 2K and M). In the spinal cord,
netrin immunoreactivity was restricted to the floor plate
(Fig. 2L). Netrin immunoreactivity was also detected in
cells within the mesenchyme of the developing dorsal pan-
creatic bud as early as E5 (Fig. 2M). Since the cells that
secrete netrins may do so constitutively and not store them
intracellularly, these cells may be difficult to demonstrate by
immunocytochemistry. To identify cells that synthesize ne-
trins, segments of gut were thus incubated with brefeldin A,
which causes the Golgi apparatus and endoplasmic reticu-
lum to fuse into a single compartment, within which even
constitutively secreted products accumulate (Klausner et al.,
1992). Following incubation with brefeldin A, cells were no
longer surrounded by netrin-immunoreactivity, which in-
stead was now found within cells of the outer gut mesen-
chyme and in the basal cytoplasm of mucosal epithelial cells
(Fig. 2N). These are likely to be the cells of the chick gut in
which netrin-2 is synthesized. The congruent localization of
netrin immunoreactivity after brefeldin A (Fig. 2N) and that
of transcripts encoding netrin-2 (Fig. 2K and M) supports
the idea that these are the sites of netrin expression in the
developing chick bowel.
The locations of sites of netrin immunoreactivity in the
developing (E13) mouse spinal cord (Fig. 2O), gut (Fig.
2P), and pancreas (Fig. 2Q) were similar to those of the
chick. Netrin immunoreactivity displayed a more cellular
pattern of localization in the outer gut mesenchyme than in
the chick; the cells, moreover, were located in the region of
the presumptive myenteric plexus (Fig. 2P). Again, consid-
erable immunoreactivity was found at the base of the mu-
cosal epithelium. The pancreatic netrin immunoreactivity
was concentrated around the basolateral borders of acinar
cells (Fig. 2Q). The sites of netrin immunoreactivity were
not coincident with those of glucagon, which was immuno-
stained in the same sections to locate developing islets of
Langerhans (Fig. 2R, compare with Fig. 2Q). The netrin
immunoreactivity was most intense, however, near devel-
oping islet cells.
Netrin receptors are expressed in the developing gut and
pancreas of chicks and mice
Expression of DCC and neogenin was analyzed in the
gut of fetal mice by using RT-PCR. The brain was also
studied as a positive control. Transcripts encoding DCC and
neogenin were detected at E11, the earliest age examined,
and they continued to be expressed in the gut through P14
(Fig. 3A). Transcripts encoding both DCC and neogenin
were also found in the E14 mouse brain (Fig. 3A). DCC has
not yet been sequenced in chicks; therefore, in the chick, the
expression of transcripts encoding neogenin, but not of
encoding DCC was investigated with RT-PCR (Fig. 3B).
Transcripts encoding neogenin were detected in both the
foregut and hindgut of chicks at E4, the earliest age exam-
ined, and continued to be present through E19 (Fig. 3B).
Transcripts encoding neogenin were also found in the E11
chick brain (Fig. 3B).
The chick gut contains protein that reacts in immuno-
blots with antibodies to human DCC (Fig. 3C). A major
band (100 kDa) and a weaker band (150–160 kDa),
were seen (Fig. 3C, lane 1). The DCC gene encodes a group
of structurally similar proteins of molecular mass 150–
190 kDa (Fazeli et al., 1997; Hedrick et al., 1994; Pierceall
et al., 1994). DCC, however, is cleaved by caspases 20 and
40 kDa from its C-terminal end (Mehlen et al., 1998), and
its ectodomain is shed from cells through the actions of
Fig. 4. The cellular locations of DCC transcripts and immunoreactivity were analyzed in the developing gut rats, mice, and chicks by in situ hybridization
and immunocytochemistry. (A) Rat duodenum at E15.5. Antisense probe. Label is present in the myenteric plexus (upper arrow) and in the primordial
submucosal plexus (lower arrow). (B) Rat duodenum at E15.5. Sense probe. No cells are labeled. (C) Mouse spinal cord at E12 (positive control). Antisense
probe. Transcripts encoding DCC are found in commissural neurons and motor columns. (D) Mouse small intestine at E13. Antisense probe. Transcripts
encoding DCC are located in cells external to the developing circular muscle where myenteric ganglia form (arrows) and in some mucosal epithelial cells.
(E) Mouse small intestine at E13. Sense probe. No cells are labeled. DCC immunoreactivity is expressed in the developing gut and pancreas of E13 mice
and E5 chicks. (F) Mouse gut and pancreas at E13 immunostained with antibodies to glucagon to identify the presumptive pancreas and to locate developing
islets of Langerhans. The dorsal pancreatic bud is adjacent to the fetal gut. The marker () indicates the location of the DCC-immunoreactive cells that are
illustrated in the field outlined by the circle in (G). (G) DCC-immunoreactive cells in the E13 mouse pancreas found at the location indicated by the () in
(F). (H) Confocal image. Double label immunocytochemical demonstration of DCC (green) and the neural marker PGP 9.5 (red) in the region of the
primordial myenteric plexus of the E13 gastric antrum. Coincident labeling is found in many cells (yellow; arrows), while others express only DCC or PGP9.5
immunoreactivities. A dense bundle of DCC-immunoreactive nerve fibers enters the field at the left. (I) Confocal image. DCC-immunoreactive cells in the
primordial myenteric plexus of the E13 mouse gut. (J) Confocal image. DCC immunoreactivity in the E13 mouse spinal cord (positive control). (K) Chick
spinal cord (positive control). Neurons exhibit DCC immunoreactivity (arrow). (L, M) Chick gut E5. DCC immunoreactivity is present in the myenteric
plexus and in mucosal epithelial cells (arrows). (N) Mouse spinal cord at E13. Adenosine A2b receptor immunoreactivity is present in many cells (arrow).
(O) Mouse small intestine at E13. The myenteric plexus (arrow) contains adenosine A2b receptor immunoreactivity. Scale bars: (A, B) 50 m; (C–E) 100
m; (F) 100 m; (G–I) 25 m; (J–H) 100 m; (N, O) 50 m.
Fig. 5. Enteric crest-derived cells migrate toward co-cultured sources of netrin-1. (A, C) An explant of E5 quail gut was cocultured with netrin-I-expressing
HEK293 cells. Quail cells were identified by immunoreactivity with QCPN antibodies (A, Cy3, red fluorescence). The position of the grafts was determined
by interference contrast microscopy. Quail cells migrate out of the gut toward the cocultured netrin-expressing cells. (B, D) Quail gut was cocultured with
control nontransfected HEK293 cells. QCPN-immunoreactive cells do not leave the explants of gut (B) and do not migrate toward the cocultured HEK293
cells (D). (E–H) Crest-derived cells were immunoselected from the E6 chick gut with HNK-1 antibodies. The isolated enteric crest-derived cells were
cocultured with three-dimensional collagen gels containing HEK293 cells that either expressed netrin-1 (E, G) or were nontransfected controls (F, H). Note
that HNK-1-immunoreactive crest-derived cells (arrow, Cy3 red fluorescence) became oriented toward the netrin-1-expressing, but not the control HEK293
cells (PGP9.5-immunoreactive, FITC green fluorescence). Scale bars: (A, C) 50 m; (B, D) 100 m; (E, F) 500 m; (G, H) 125 m.
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metalloproteases of the ADAM class (Galko and Tessier-
Lavigne, 2000). Immunoblotting was thus repeated by using
caspase inhibitor VI and MMP inhibitor III. When this was
done, major bands became apparent in the immunoblots at
130 and 150 kDa, while the relative intensity of the
100-kDa band decreased (Fig. 3C, lane 2). These data are
consistent with the ideas that chick DCC migrates at 160
kDa, that it is a substrate for caspases and metalloproteases,
that the ectodomain, which remains after caspase and/or
metalloproteases cleavage, is 100 kDa, and that chick
DCC is recognized by antibodies to human DCC.
In the bowel of the E11 mouse, the level of expression of
DCC was found by competitive PCR to be low (Fig. 3D).
The expression of DCC increased sharply on day E13,
declined moderately by E15, and then more rapidly by E17.
By the time of birth, the level of DCC expression was less
than that at E11 and declined still further to reach a very low
level of expression that was maintained through P14 (Fig.
3D). The level of expression of neogenin was relatively high
early in the development of the chick gut, at E5, but then
gradually declined through E19 (Fig. 3E). The expression of
the adenosine A2b receptor was examined in the developing
chick gut, even though its role in netrin signaling is not
clearly established. The adenosine A2b receptor was found
to be expressed in the chick bowel during early develop-
ment, at E15, but its expression declined as a function of age
(Fig. 3F) even more sharply than did that of neogenin.
Transcripts encoding neogenin and the adenosine A2b re-
ceptor were also observed in the chick pancreas; the level of
expression of neogenin in the pancreas did not change
between E7.5 and E13, but that of the adenosine A2b
receptor declined (Fig. 3G).
In situ hybridization was used to locate sites of expres-
sion of DCC in the developing bowel of rats (E15.5) and
mice (E13). The expression of mRNA encoding DCC in the
E12 mouse spinal cord, where it is known to be expressed
by commissural neurons and the developing motor columns
(Keino-Masu et al., 1996), was used as a positive control. In
the E15.5 rat, mRNA encoding DCC was observed in the
outer mesenchyme, in the region of the primordial myen-
teric and submucosal plexuses (Fig. 4A). In the mouse,
strong labeling of developing cells was found in developing
myenteric ganglia (Fig. 4D). The antisense probe also re-
vealed the mRNA encoding DCC, as expected, in commis-
sural neurons and the developing motor columns of the E12
mouse spinal cord (Fig. 4C). No labeling was detected when
adjacent sections were hybridized with a sense riboprobe
(Fig. 4B and E).
DCC and adenosine A2b immunoreactivities are
expressed in the bowel by cells in a neural lineage
The immunoreactivities of DCC and the adenosine A2b
receptor were located in the gut and pancreas of the E13
mouse and in the gut and spinal cord (which was processed
as a positive control) of the E7 chick. Glucagon immuno-
reactivity was used to confirm the identification of the
developing mouse pancreas and to locate primordial islets
of Langerhans (Fig. 4F). DCC immunoreactivity was found
to be located in scattered cells within the pancreas (Fig. 4G),
where they were close to but not coincident with the islets
(see the marker in Fig. 4F). Vagal nerve fibers descending in
the wall of the stomach were found in a thick DCC-immu-
noreactive nerve bundle (Fig. 4H). These fibers terminated
within the presumptive myenteric plexus where DCC-im-
munoreactive cells were found (Fig. 4H and I). A subset of
these DCC-immunoreactive cells displayed coincident la-
beling with the immunoreactivity of the neuronal marker,
PGP9.5, and the doubly labeled cells, in turn, were a subset
of the PGP9.5-immunoreactive population. Some, but not
all of the DCC-immunoreactive cells, therefore, have al-
ready developed as neurons, and some but not all of the
developing enteric neurons at E13 contain DCC. Bundles of
DCC-immunoreactive neurites were also observed in the
primordial myenteric plexus of the presumptive stomach
and duodenum (Fig. 4I). Many axons, including commis-
sural axons were also DCC-immunoreactive in the E13
mouse spinal cord (Fig. 4J), which was examined as a
positive control. DCC immunoreactivity was also located in
the E5 spinal cord (Fig. 4K) and gut (Fig. 4L and M) of
chicks. Cold acetone fixation was found to be necessary to
demonstrate immunoreactivity in chick tissue, possibly be-
cause the antibodies (the same as used for the immunoblots
described above) were directed against a mammalian pro-
tein. Immunoreactivity was found in the spinal cord in a
pattern that was consistent with the immunostaining of
dorsal and ventral commissural neurons (Fig. 4K). In the
chick bowel, DCC immunoreactivity was seen in the devel-
oping myenteric plexus and the epithelium mucosa (Fig. 4L
and M). The basal surface of mucosal epithelial cells was
distinctly immunostained in the chick intestine (Fig. 4M).
Adenosine A2b receptor immunoreactivity was found in
neurons of the E13 mouse spinal cord (Fig. 4N) (Puffin-
barger et al., 1995; Stehle et al., 1992) and the myenteric
plexus of the small intestine (Fig. 4O).
Netrin-1 attracts migrating enteric crest-derived cells by
affecting DCC
Netrin-1 attracts enteric crest-derived cells
Explants of quail small intestine were cocultured with
stably transfected HEK 293 cells that expressed netrin-1.
The explants were embedded in a collagen gel to allow
gradients to form and to prevent the dispersal of the HEK
293 cells. Control explants were cocultured with parent
nontransfected HEK 293 cells. Cells from the explants of
gut were identified immunocytochemically with QCPN an-
tibodies (Table 1), while the HEK 293 cells were identified
by interference contrast microscopy. Quail cells were found
to migrate out of the explants of intestine and grow toward
netrin-1-expressing (Fig. 5A and C), but not control (Fig.
5B and D) HEK 293 cells. The quail cells did not leave
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Fig. 6. Crest-derived cells migrate inwardly by a DCC-dependent mechanism in cultured rings of bowel. E5 chick gut was cut transversely and grown in organotypic
tissue culture. (A) Control, no additives. HNK-1 immunoreactive crest-derived cells (arrow) migrate in toward the center of the cultures. (B) Antibodies to DCC.
The inward migration of crest-derived cells is prevented and they remain frozen in their original locations at the periphery of the bowel. (C) SP-cAMPS. Crest-derived
cells (arrow) continue to migrate inwardly. (D) RP-cAMPS. Crest-derived cells fail to migrate inwardly. (E) Antibodies to HNK-1. Crest-derived cells (arrow)
continue to migrate inwardly. (F) Antibodies to PGP9.5. Crest-derived cells (arrow) continue to migrate inwardly. (G, H) The absence (G) or presence (H) of
antibodies to the adenosine A2b receptor does not detectably affect the inward migration of crest-derived cells. Scale bars: (A–H) 100 m.
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regions of the explants of gut that were not apposed to the
netrin-1-expressing cells.
In a second set of experiments, crest-derived cells were
immunoselected from the E6 chick gut (Pomeranz et al.,
1993) and layered over HEK 293 cells that were embedded
in a collagen gel. The crest-derived cells of the chick were
visualized immunocytochemically with HNK-1 monoclonal
antibodies. The HEK 293 cells were identified with anti-
bodies to PGP9.5, which react with HEK 293 cells, but not
with chick crest cells. The crest-derived cells migrated to-
ward the HEK 293 cells when the HEK 293 cells were
netrin-1-secreting (Fig. 5E and G); however, there was no
detectable directional migration of crest-derived cells when
they were plated over control HEK 293 cells (Fig. 5F and
H).
Antibodies to DCC block the inward migration of crest-
derived cell in intestinal explants
The E5 chick gut was explanted and cut transversely so
that it could be grown in a ring configuration in organotypic
tissue culture. When this was done, the crest-derived cells,
which were originally in the outer gut mesenchyme (Ger-
shon et al., 1993; McKeown et al., 2001; Payette et al.,
1984) (see Fig. 4L), migrated inward toward the mucosa
(Fig. 6A). HNK-1 immunoreactivity was used as a marker
for crest-derived cells. The inward migration of crest-de-
rived cells was blocked by antibodies to DCC, which froze
the cells in their positions at the periphery of the ring of
bowel (Fig. 6B). The response to DCC stimulation is me-
diated by cAMP and PKA (Ming et al., 1997); therefore, the
response of cells to netrins can be inhibited by the PKA
antagonist, Rp-cAMPS, but not by the agonist, Sp-cAMPS.
Exposure of cultures to Sp-cAMPS did not prevent the
inward migration of crest-derived cells in ring cultures of
gut (Fig. 6C); however, Rp-cAMPS abolished this migra-
tion, as did the antibodies to DCC (Fig. 6D). The addition of
control antibodies, HNK-1 (Fig. 6E) or PGP9.5 (Fig. 6F), to
the ring cultures was without effect on the inward migration
of crest-derived cells. Exposure of the ring cultures to an-
tibodies to the adenosine A2b receptor also failed to prevent
the inward migration of crest-derived cells (Fig. 6G and H).
These experiments suggest that a DCC-dependent mecha-
Fig. 7. Crest-derived cells migrate out of the gut toward co-cultured explants of pancreas; this migration is DCC-dependent. E5 chick gut was preincubated
with CellTracker Green and then grown for 2 days in organotypic tissue culture with an explant of dorsal pancreatic bud. Crest-derived cells were identified
by their HNK-1 immunoreactivity (Cy3, red fluorescence). (A) Control, no additives. Doubly labeled (CellTracker Green/HNK-1 immunoreactive)
crest-derived cells (arrow) from the gut (g) migrate toward the nonfluorescent pancreatic bud (p). (B) Antibodies to DCC. Doubly labeled crest-derived cells
(arrow) remain in the gut (g) and do not migrate toward the pancreatic bud (p). (C) SP-cAMPS. Doubly labeled crest-derived cells (arrow) from the gut (g)
migrate toward the pancreatic bud (p). (D) RP-cAMPS. Doubly labeled crest-derived cells (arrow) remain in the gut (g) and do not migrate toward the
pancreatic bud (p). Scale bars: (A–D) 100 m.
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nism attracts crest-derived cells that are migrating proximo-
distally in the outer gut mesenchyme to turn in the perpen-
dicular direction and migrate toward the mucosa. The data
do not support the idea that the adenosine A2b receptor is a
necessary coreceptor for this function of DCC. The mucosa,
which expresses netrins, might be the source of endogenous
agonist to stimulate DCC on crest-derived cells. The inward
migration of a subset of crest-derived cells could be impor-
tant in the formation of the submucosal plexus of the small
bowel.
Antibodies to DCC inhibit the migration of crest-derived
cells from gut toward pancreas
Explants of E5 chick foregut were labeled by incubation
with CellTracker Green and then cocultured for 2 days with
dorsal pancreatic buds explanted at the same age. HNK-1
immunoreactivity was used to mark crest-derived cells;
therefore, those crest-derived cells that are of enteric origin
would be doubly labeled by CellTracker Green and HNK-1,
while crest-derived cells that were in the pancreatic buds at
the time of explantation, if any, would only be HNK-1-
immunoreactive. Doubly labeled crest-derived cells were
found to migrate away from the explants of bowel in the
direction of the cocultured pancreatic bud (Fig. 7A). Few
such cells migrated out of the enteric explants from surfaces
that were not apposed to the pancreatic buds. When anti-
bodies to DCC were included in the culture medium, no
crest-derived cells migrated out of the explants of bowel
(Fig. 7B). The exposure of cultures to Sp-cAMPS did not
prevent the migration of doubly labeled crest-derived cells
out the bowel in the direction of the pancreatic buds (Fig.
7C); however, this migration was blocked by Rp-cAMPS
(Fig. 7D). These observations are consistent with the idea
that the migration of crest-derived cells from the foregut to
the pancreas (Kirchgessner et al., 1992) is a DCC-dependent
response to the secretion of an attractant, probably a netrin.
Pancreatic and submucosal ganglia are absent in
transgenic mice that lack DCC
Transgenic mice that lack DCC were investigated to test
the hypotheses that chemoattractants secreted by the mu-
cosa and pancreas induce DCC-expressing crest-derived
cells in the small intestine to deviate from their proximo-
distal path of migration to enter, respectively, the submu-
cosa and the pancreas. Antibodies to PGP9.5 were used as
a marker for cells developing in a neural lineage. AChE
activity was also demonstrated histochemically in some
preparations to confirm the identification of pancreatic gan-
glia. At E12.5, the myenteric plexus of the wild-type gut is
highly PGP9.5-immunoreactive and the primordial pancreas
contains numerous PGP9.5-immunoreactive cells that have
begun to form small ganglia (Fig. 8A and C) In contrast, the
pancreas at the same age contains no PGP9.5-immunoreac-
tive neurons (Fig. 8B and D), although the PGP9.5 immu-
noreactivity of the myenteric plexus of the DCC/ mice
resembles that of wild-type animals (not illustrated). At
E15.5, a thin ring of submucosal plexus can be recognized
as beginning to form in wild-type (Fig. 8E), but not in
DCC/ animals (Fig. 8F and H). Pancreatic neurons are
also present in wild-type (Fig. 8E and G) but not in DCC/
mice (Fig. 8F and H). At P0, pancreatic neurons could again
be recognized in the pancreas of wild-type animals (Fig. 8I
and K), but they were still absent from the pancreas of
DCC/ mice (Fig. 8J and L). By this age the close rela-
tionship of pancreatic ganglia to Islets of Langerhans was
evident in wild-type mice (Fig. 8K). Evidence of the for-
mation of a submucosal plexus was still not apparent in the
P0 DCC/ animals (Fig. 8L). The small pancreatic ganglia
of wild-type P0 mice displayed typical AChE activity (Fig.
8M); no AChE-stained ganglia were evident at P0 in
DCC/ mice (Fig. 8N). These observations are consistent
with the idea that netrins secreted by the intestinal mucosa
and the pancreas play roles, respectively, in the formation of
the submucosal plexus and pancreatic ganglia.
Netrin-1 promotes the development and/or survival of
enteric crest-derived cells
DCC is thought to induce apoptosis when it is deprived
of ligand binding, but to promote survival when it is en-
gaged by netrin-1 (Forcet et al., 2001; Mehlen et al., 1998).
If a subset of crest-derived cells expresses functional DCC,
therefore, then their development/survival would be ex-
pected to be promoted by netrin-1. This hypothesis was
tested. The E7 chick gut was dissociated and the resulting
cell suspension was either plated directly on collagen-
coated coverslips for culture or subjected to immunoselec-
tion with HNK-1 antibodies to isolate crest-derived cells.
Cultures of mixed cells from the dissociated bowel or iso-
lated crest-derived cells were then exposed to netrin-1
(0.02-1.0 g/ml). Netrin-1 was found to increase the num-
ber of crest-derived cells, identified immunocytochemically
with HNK-1 antibodies, in both types of culture; however,
the efficacy of netrin-1 was substantially greater for the
cultures of immunoselected cells (Fig. 9A). The concentra-
tion-effect relationship for netrin-1 was bell-shaped; the
maximal development/survival was reached at 0.5 g/ml
and declined at 1.0 g/ml. At the optimum concentration of
netrin-1, the mean number of surviving crest-derived cells
was 171% of control (P  0.02) in cultures of mixed cells
and 261% of control (P  0.0001) in cultures of immuno-
selected cells. Netrin-1 thus promotes the in vitro develop-
ment/survival of enteric crest-derived cells. The effect of
netrin-1 does not require the secretion of a cofactor pro-
duced by non-crest-derived cells. Exogenous netrin-1 prob-
ably exerts a greater effect in cultures of isolated crest-
derived cells than in cultures of mixed cells from the gut
wall because endogenous mesenchymal cells, which are
included in the latter cultures, express netrin-1.
Netrin-1 promoted the outgrowth of neurites as well as
the development/survival of enteric crest-derived cells;
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however, netrin-1 was only able to do so in cultures of
mixed cells of the gut wall. Process bearing cells (PBCs)
were defined as those extending neurites 3-fold the max-
imal diameter of the perikaryon. In control cultures of
mixed cells (Fig. 9B), PBCs constituted 9.3  3.4% of the
total number of HNK-1-immunoreactive crest-derived cells;
netrin-1 (0.5 g/ml) increased this proportion to 17.9 
1.7% (P 0.05). Netrin-1 did not significantly increase this
proportion in cultures of isolated crest-derived cells (Fig.
9B). These data suggest that the promotion of neurite ex-
tension by netrin-1 requires co-factor(s) produced by non-
crest-derived cells of the bowel wall.
Discussion
The current study was undertaken to test the idea that
netrins function as guidance molecules that attract enteric
crest-derived cells to their correct destinations in the bowel
and/or pancreas. Initial studies were designed to determine
whether the elements of the netrin signaling system (netrins
and their receptors) are present in the gut and/or pancreas at
appropriate times during development. Transcripts encod-
ing netrin-2 are expressed in the gut of chicks and those
encoding netrins-1 and -3 are expressed in the bowel of
mice. The same netrins are expressed respectively in the
chick and mouse pancreas. Netrin expression, quantified in
the chick gut by competitive PCR, is developmentally reg-
ulated, increasing during the time crest-derived cells are
migrating, particularly when the submucosal plexus is
formed (Allan and Newgreen, 1980; Burns and Le Douarin,
1998; McKeown et al., 2001; Payette et al., 1984), and
decreasing afterward. Sites of mRNA encoding netrins in
the bowel, located by in situ hybridization, and sites of
netrin protein concentration, located by immunocytochem-
istry, are similar in mice and chicks; both mRNA and netrin
immunoreactivity are found in the basal regions of mucosal
epithelial cells and in the outer gut mesenchyme where
netrin-1 RNA and netrin immunoreactivity were found in
the region of developing myenteric ganglia. In the pancreas,
mRNA and netrin immunoreactivity were located in the
basal region of acinar cells. Brefeldin A caused netrin im-
munoreactivity to accumulate in the same sites in the chick
gut where netrin mRNA was found by in situ hybridization,
suggesting that netrins are constitutively secreted.
DCC expression, quantified in the murine gut by com-
petitive PCR, was detectable as early as E11. Neurons are
not recognizable at this age, but crest-derived cells are
known to be present in the small intestine (McKeown et al.,
2001; Rothman and Gershon, 1982). The hindgut is colo-
nized later, at E12.5-E14.5 (McKeown et al., 2001; Roth-
man and Gershon, 1984); therefore by E13, when DCC
expression reaches a peak, many crest-derived cells are
migrating in the gut; furthermore, the period from E13 to
E15 coincides with the secondary migrations of crest-de-
rived cells in the small intestine from the outer gut mesen-
chyme to the submucosa and pancreas. The developmental
regulation of DCC, therefore, is consistent with its expres-
sion by migrating enteric crest-derived cells. Neogenin and
the adenosine A2b receptor are also expressed in the bowel;
however, their expression slowly declines as a function of
age. DCC was also found by in situ hybridization and
immunocytochemistry to be expressed by developing en-
teric neurons; mRNA encoding DCC was located in myen-
teric ganglia and DCC immunoreactivity coincided in a
subset of cells with that of the neural marker, PGP9.5. These
data suggest that a subset of enteric crest-derived cells
expresses DCC.
Several experiments confirmed that enteric crest-derived
cells are attracted by netrin-1. Cells migrate out of explants
of chick bowel toward cocultured masses of netrin secreting
cells, but they do not migrate toward similarly cocultured
cells that do not secrete netrin-1. Isolated enteric crest-
derived cells also selectively migrate in vitro toward immo-
bilized netrin-secreting cells. Experiments further suggested
that enteric crest-derived cells migrate in vitro toward en-
dogenous sources of netrins within the gut; thus, crest-
derived cells migrate toward the mucosa in explanted rings
of bowel. This inward migration was blocked by antibodies
to DCC and by the PKA inhibitor, Rp-cAMPS, but not by
antibodies to HNK-1 or PGP9.5, or by Sp-cAMPS (which
does not inhibit PKA), suggesting that the migration re-
quires DCC signal transduction. The inward migration of
crest-derived cells was not affected by antibodies to the
adenosine A2b receptor, an observation that is consistent
with the report that adenosine A2b is not an essential core-
ceptor for DCC (Stein et al., 2001). Similar results were
obtained with cocultures of gut and pancreas. Crest-derived
cells migrate from the presumptive duodenum toward ex-
plants of pancreas and this migration, like the inward mi-
gration of crest-derived cells in intestinal rings, was abol-
ished by antibodies to DCC and by RP-cAMPS.
The in vitro data suggest that netrins attract enteric crest-
derived cells and cause them to migrate by a DCC-depen-
dent mechanism toward the mucosa or pancreas. Studies of
mice lacking DCC suggest that endogenously secreted ne-
trins probably act similarly and divert the migration of a
subset of DCC-expressing crest derived cells toward the
submucosa and pancreas; thus, no evidence of the formation
of a submucosal plexus or pancreatic ganglia was observed
in the DCC knockout animals. At E12.5 crest-derived cells
are already present in the primordial pancreas of wild-type
mice, although the submucosal plexus has not yet begun to
form; however, as late as P0, the DCC-deficient mice still
lack pancreatic ganglia. By E15.5, submucosal ganglia have
begun to form in the small intestine of wild-type mice, but
again, even as late as P0 submucosal ganglia were not seen
in the DCC-deficient animals. The lack of DCC evidently
does not prevent crest-derived cells from colonizing the gut.
The bowel was encircled by PGP9.5-immunoreactive neu-
rons in both wild-type and DCC-deficient mice. Observa-
tions are thus consistent with the hypotheses that a DCC-
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expressing subset of crest-derived cells migrating in the
bowel attracted to netrins that are secreted by the mucosa;
these cells migrate inwardly through the developing circular
muscle and give rise to the submucosal plexus. The data are
also consistent with the idea that another subset of crest-
derived cells are attracted to netrins that are secreted by
pancreatic acinar cells; these crest-derived cells migrate into
pancreatic buds and give rise to pancreatic ganglia. The
abilities of vagal crest-derived cells to “home” to the bowel
and migrate proximodistally within it are probably indepen-
dent of netrin/DCC signaling and thus occur in its absence.
The crest-derived cells that are putatively attracted by
mucosal netrins do not actually reach the mucosa, although
they often do so in vitro (see Fig. 6). Additional shorter
range factor(s) may be secreted by the mucosa to act as stop
or repulsive signals, which prevent crest-derived cells from
migrating any further than the submucosa. One such factor
may be the laminin that is secreted in abundance by the
developing enteric mucosa (Chalazonitis et al., 1997b; Si-
mon-Assmann et al., 1998). Laminin converts the attractive
effects of netrin to repulsion (Hopker et al., 1999) and also
promotes the development of enteric neurons (Chalazonitis
et al., 1997b). Mucosally secreted laminin could thus repel
approaching crest-derived cells, preventing them from en-
tering the mucosa, while at the same time encouraging them
to differentiate (and thus cease to migrate) in the submu-
cosa. Alternatively, since Slit proteins and Robo receptors
are expressed in the fetal gut (J. Chen and M.D.G., unpub-
lished observations) and Robo downregulates DCC expres-
sion (Stein and Tessier-Lavigne, 2001), the failure of crest-
derived cells to enter the mucosa could be due to the
mucosal secretion of a short-range factor, such as Slit.
It is not entirely clear why, if mucosal netrin attracts
crest-derived cells, only a relatively small subset migrates
into the submucosa. DCC is expressed by only a subset of
the PGP9.5-expressing enteric crest-derived cells (see Fig.
4H); therefore, the response of some cells and not others to
the putative attraction of mucosal netrin might be explained
if only the DCC-expressing subset of neural precursors were
able respond to mucosal netrin. Timing or the expression of
a coreceptor may also be important; conceivably, only a
subset of the DCC-expressing cells may be capable of
migrating when a netrin gradient from the mucosa reaches
the outer gut mesenchyme, which itself is a source of netrin.
The netrin in the outer gut mesenchyme may function in the
attraction of vagal fibers, which were found to express
DCC, to the developing myenteric ganglia.
The presence of netrin in the outer gut mesenchyme may
Fig. 9. Netrin-1 promotes the survival of enteric crest-derived cells in vitro.
(A) Crest-derived cells were isolated from the E7 chick gut by immuno-
selection with antibodies to HNK-1 and cultured in the absence (control) or
presence of ascending concentrations of netrin-1 (solid line). Alternatively,
dissociated cells from the bowel were exposed to ascending concentrations of
netrin-1 without prior immunoselection (dashed line). The number of surviv-
ing crest-derived cells (identified as HNK-1-immunoreactive) in each culture
was determined, normalized as a percent of control (number of cells surviving
in the absence of netrin-1), and the calculated means for isolated and mixed
cells were plotted as a function of the netrin-1 concentration. The addition of
netrin-1 promoted the survival/development of crest-derived cells in cultures
of isolated cells to a greater extent than it did their survival in mixed cultures.
The effect of netrin-1 was concentration-dependent but lost at a high concen-
tration of the ligand. (B) The proportion of crest-derived cells that extended
processes was quantified in cultures of isolated crest-derived (solid line) and
mixed cells (dashed line) from the gut. Netrin-1 promoted the extension
neurites (by HNK-1-immunoreactive cells) in cultures of mixed cells than to a
greater extent than it did in cultures of isolated enteric crest-derived cells.
Fig. 8. Submucosal and pancreatic ganglia are not seen in DCC/ mice. Sections showing the developing duodenum and bowel in wild-type and DCC/
mice are compared at E12.5 (A–D), E15.5 (E–H), and PO (I–N). The sections from wild-type mice are in the vertical rows (A, E, I, M and C, G, K) while
the DCC/ mice are in the vertical rows (B, F, J and D, H, L, N). Neurons (arrows) are demonstrated immunocytochemically with antibodies to PGP9.5
(A–L) and by visualizing AChE activity (M, N). g, gut; p, pancreas. Note that primordial pancreatic ganglia with PGP9.5-immunoreactive cells can be
discerned at all ages in wild type mice but not DCC/ animals. A primordial submucosal plexus has begun to form in wild-type mice by E15.5 (E) and
is seen also at PO (K) but is not present in the DCC/ bowel at this age or even at PO (J, L). Scale bars: (A–H) 50 m; (I–N) 100 m.
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be important in preventing premature apoptosis among the
migrating crest-derived cells, because in the absence of
ligand, DCC mediates apoptosis (Forcet et al., 2001; Llambi
et al., 2001; Mehlen et al., 1998). The ability of netrins to
prevent DCC-mediated apoptosis is likely to account for the
promotion by netrin-1 that we observed in the development/
survival of cultured crest-derived cells. No loss of myenteric
cells was observed in DCC knockout mice. The knockout of
DCC, however, would not be expected to increase cell death
because the DCC-related apoptosis is actually DCC medi-
ated. No observations have yet been made on mice lacking
both netrins-1 and -3. Such mice would be expected to be
deficient in the numbers of crest-derived cells that survive in
the bowel. It is not clear how DCC-expressing cells in the
outer gut mesenchyme escape the presumptive attraction of
the source of netrin in the presumptive circular muscle layer
to migrate toward the sources of netrin in the mucosa and
pancreas. It is conceivable that the concentrations of netrins
and the resulting gradients are patterned so as to favor
migration toward the mucosa and pancreas. In addition, it is
possible that netrins are presented to crest-derived cells
more effectively in or near the mucosa than in the smooth
muscle. The DCC expressed by the mucosa may facilitate
its accumulation in this location.
In following a putative netrin gradient, the DCC-express-
ing subset of crest-derived cells must choose whether to
migrate toward the mucosa or in the opposite direction
toward the pancreas. It seems likely that only those crest-
derived cells that express DCC as they migrate past the
pancreatic buds are in a position to respond to the pancreatic
netrin gradient. The remainder of the population would be
expected to respond only to the mucosal source of netrin.
The developmental regulation of DCC expression in the gut
would also imply that the time during which crest-derived
cells could be attracted to the pancreas is brief. The restric-
tions in time and space of the potential for attracting enteric
crest-derived cells to migrate into the pancreas are likely to
limit the loss of such cells from the gut and the number of
neurons that ultimately arise in pancreatic ganglia.
Our observations strongly support the idea that netrins
and their receptor, DCC, play critical roles in the develop-
ment of the ENS and the innervation of the pancreas. Netrin/
DCC signaling appears to be most crucial in the formation
of the submucosal and pancreatic plexuses; however, netrin/
DCC signaling may also play roles in the establishment of
the extrinsic vagal innervation of the intestinal ganglia, the
development of intraenteric connections, and the regulation
of apoptosis.
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